AstraZeneca Cancer Drug Sales Fuel Profit Beating Estimates

(Bloomberg) -- AstraZeneca Plc’s sales of cancer drugs surged in the most recent quarter, helping drive profit and revenue beyond analysts’ expectations.

Bloomberg Quint

Add BloombergQuint App to Home screen.